CONTOUR® NEXT EZ - Blood Glucose Monitoring System. 1 kit. For - ASCENSIA DIABETES CARE US INC.

Duns Number:080028910

Device Description: Blood Glucose Monitoring System. 1 kit. For self-testing, monitoring and management of b Blood Glucose Monitoring System. 1 kit. For self-testing, monitoring and management of blood glucose.This kit contains the following items: CONTOUR® Next EZ Blood Glucose Meter; User Guide; Quick Reference Guide; Lancing Device; 10 Colored Lancets (provided sterile); Logbook; Carrying Case.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

7252

Brand Name

CONTOUR® NEXT EZ

Version/Model Number

7252

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

Yes

Over the Counter (OTC)

Yes

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K111268,K130265,K162336,K111268,K162336,K130265

Product Code Details

Product Code

LFR

Product Code Name

Glucose Dehydrogenase, Glucose

Device Record Status

Public Device Record Key

42f4310f-7b32-4ccf-921d-b30592b9fa54

Public Version Date

July 06, 2018

Public Version Number

3

DI Record Publish Date

September 16, 2016

Additional Identifiers

Package DI Number

40301937252011

Quantity per Package

4

Contains DI Package

00301937252013

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

shipper/case

"ASCENSIA DIABETES CARE US INC." Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 7
2 A medical device with a moderate to high risk that requires special controls. 19
3 A medical device with high risk that requires premarket approval 2